tak 676,pembrolizumab
merck,takeda
['tnbc', 'nsclc', 'lung', 'tak-676', 'breast', 'pembro', 'head and neck', 'sclc']
#cedarssinaicancer at #asco22. the phase 1 study looking at tak-676 + pembrolizumab for advanced non small cell lung cancer, triple-negative breast cancer, or squamous-cell #carcinoma of the head and neck is being presented. #nsclc #tnbc 
Cedars-Sinai Cancer, ranked #9 in the nation in 2021 by U.S. News & World Report.